Task: Answer the multiple choice question.
Question: Which drug exhibits a -3.096% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CC(NC(=O)OCc1ccccc1)C(=O)N(C)Cc1ccc(C(C)C)cc1
b O=C(CSc1nc(-c2ccccc2)cc(=O)[nH]1)Nc1ccc(F)c(F)c1
Answer: a. CC(NC(=O)OCc1ccccc1)C(=O)N(C)Cc1ccc(C(C)C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(NC(=O)OCc1ccccc1)C(=O)N(C)Cc1ccc(C(C)C)cc1
CC(NC(=O)OCc1ccccc1)C(=O)N(C)Cc1ccc(C(C)C)cc1
benzyl N-[1-[methyl-[(4-propan-2-ylphenyl)methyl]amino]-1-oxopropan-2-yl]carbamate